• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Therapeutic Effect of Mesenchymal Stem Cells Overexpressing Interleukin-10 on Inflammatory Bowel Disease

    2022-10-26 04:03:58LUXinZHAOTaoRanCHENGHaiQinLIXueWeiLIANGTingXUXinRuiHUZiXuanMALiHuiZHANGChunHongCHENChunTingWANGLeiXIEJunLIUZhiZhenZHAOHong

    LU Xin, ZHAO Tao-Ran*, CHENG Hai-Qin, LI Xue-Wei, LIANG Ting, XU Xin-Rui,HU Zi-Xuan, MA Li-Hui, ZHANG Chun-Hong, CHEN Chun-Ting, WANG Lei, XIE Jun,LIU Zhi-Zhen, ZHAO Hong*

    (1)Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Department of Biochemistry and Molecular Biology, Shanxi Medical University,Taiyuan 030001, China; 2)Department of Rheumatology and Immunology, The First Affiliated Hospital of Hainan Medical College, Haikou 570100, China)

    Abstract Inflammatory bowel disease (IBD) is an intractable inflammatory autoimmune disease characterized by T-cell infiltration to the colon. Mesenchymal stem cells (MSCs), owing to their immunosuppressive capabilities, have the potential to rescue IBD. But the therapeutic effectiveness of MSCs is sometime thwarted by their variable immunomodulatory ability in vivo. In the present study, we produced engineered MSCs that secrete interleukin10 (IL-10) and evaluated their therapeutic potential in IBD mouse model. The MSCs maintained the phenotype and cell proliferation rate after overexpression of IL-10 by lentivirus (LV) infection. Immune cells and MSCs in vitro co-culture systems exhibited that relative to unmodified MSCs, immune cells co-cultured with IL-10-overexpressing MSCs had significantly lower numbers of T helper 1 cells (Th1) and T helper 17 cells (Th17) (P<0.05), the content of TNF-α in the supernatant of macrophage cells co-cultured with MSCs overexpressing IL-10 was significantly decreased (P<0.0001). Tail vein injection of the IL-10 overexpressing MSCs achieved a better therapeutic effect in the dextran sodium sulfate (DSS) induced colitis mouse model than that of the unmodified MSCs, as indicated by colon length, disease activity index (DAI) and colonic cytokines expression. The experimental results were statistically different (P>0.05). Overall, LV induced MSCs overexpressing IL-10 might be a promising alternative therapeutic option for the treatment of IBD.

    Key words inflammatory bowel disease (IBD); mesenchymal stem cells (MSCs); interleukin-10 (IL-10); cytokines secretion; T helper cells differentiation

    Inflammatory bowel disease (IBD) is a set of multifactorial autoimmune disorders defined by persistent nonspecific inflammation in the intestines and includes two primary clinical subgroups, Crohn’s disease (CD) and ulcerative colitis (UC)[1]. It is usually a complex disorder with multiple factors such as genetic mutations, gut microbiome dysbiosis, psychological distress, autonomic dysfunction and hyperactivation of immunity[2].

    Among those factors, recent literature showed that abnormal innate and adaptive immunity is the most essential pathogenesis in the development of UC and CD[3]. T helper 1 cells (Th1), showing increased interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) expression, have been implicated in murine models and in patients with IBD[4]. T helper 17 cells (Th17) preferentially produce interleukin-17 (IL-17) and IL-22, leading to recruitment and activation of granulocytes and macrophages which are tissue-damaging[5]. IBD pathogenesis is also related to M1 macrophages that produce reactive oxygen and nitrogen species, as well as pro-inflammatory cytokines (TNF-α, IL-6). Uncontrolled M1 macrophage activity, on the one hand, might cause tissue damage and predispose the host to neoplastic tumors[6]. Macrophage-produced mediators, on the other hand, enhance the activation and differentiation of Th1 and Th17 cells[7].

    Due to their anti-inflammation, multi-differentiation and tissue repair activities, mesenchymal stem cells (MSCs), particularly bone marrow-derived mesenchymal stem cells (BM-MSCs), are a good candidate for the therapy of IBD[8, 9]. MSCs possess immune suppressive effects by the inhibition of T cells and monocytes function via cell-to-cell contact or paracrine activity[10]. Immunomodulatory substances such as IL-10, transforming growth factor-β (TGF-β), and prostaglandin E2 (PGE2) are secreted by MSCs and play an important role in their therapeutic potential[9]. However, in the complicated pathogenic contexts, MSCs immunomodulatory function is very variable[11, 12]. Therefore, developing strategies that can improve and optimize the paracrine actions of MSCs then strengthen the effectiveness of MSC-based treatment is highly desired.

    IL-10 is an anti-inflammatory cytokine which mainly regulates inflammatory reaction of immune cells. Specifically, IL-10 suppresses macrophage activation, T cell proliferation and pro-inflammatory cytokine (such as IFN-γ, IL-2 and TNF-α) secretion from Th1 cells[13, 14]. For the first time, a GWAS study was carried out to reveal the involvement between IL-10 and UC[15]. Polymorphisms in the IL-10 promoter have been connected to IBD and have been proven to modify IL-10 serum levels in studies[16-18]. Clinical studies have shown that IL-10 supplementation therapy is beneficial to the IBD patients, particularly those with low IL-10 serum levels or high disease activity[19, 20]. However, solely IL-10 is insufficient to inhibit all of the pro-inflammatory mediators involved in IBD. Furthermore, the dose used in past IL-10 treatments cannot results in a high enough IL-10 concentration in the intestine which can elicit a response[21].

    In this study, the potential enhancement of therapeutic efficiency of IL-10-overexpressing MSCs in a dextran sodium sulfate (DSS)-induced murine colitis model was investigated. The IL-10 transduction in BM-MSCs was achieved by lentivirus (LV) infection. Compared to the blank control group, the IL-10-overexpressing MSCs significantly improved the therapeutic effect. In addition, the IL-10-overexpressing MSCs significantly down-regulated the proportion of Th1 and Th17 cells in lymphocytes and the secretion of TNF-α from macrophages. Our results may provide helpful information for guiding the development of stem-cell-based therapies in treating IBD.

    1 Materials and Methods

    1.1 Reagents and animals

    Dextran sodium sulfate (DSS, molecular weight, 36-50 kD) was obtained from MP Biomedicals (USA). Fluorescence-conjugated mAbs against rat CD11b, CD45, CD90 and CD29 (#201807, #202211, #202529, #17-0291-80) and against mouse CD4, CD25, IFN-γ and IL-17A antibody (#100431, #101903, #505841, #506915) were purchased from BioLegend (USA). Female C57BL/6 mice (6-8 weeks old) and male Sprague-Dawley (SD) rat (4 weeks old) were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd (China) and maintained in a specific pathogen-free (SPF) environment. All animal experiments were approved by and performed in compliance with the guidelines of the Ethics Committee of Animal Care and Use Committee of Shanxi Medical University.

    1.2 Isolation and culture of MSCs

    MSCs were isolated from the hindlimbs of SD rats under sterile circumstances and grown with complete culture medium [Modified Eagle Medium: F-12 (DMEM/F-12; Life Technologies, USA) containing 10% fetal bovine serum (FBS; Life Technologies), and an antibiotics mixture (100 U/mL penicillin and 100 mg/mL streptomycin (Beyotime Biotechnology, China)] at 37 ℃ in a humidified atmosphere with 5% CO2. The MSCs were passaged at a ratio of 1∶2 in triple flasks when cells reached 80%-90% confluence. All experiments used MSCs passaged no more than six times.

    1.3 Construction and phenotypic determination of modified MSCs

    LV vectors encoding mouse IL-10 (GenBank: NM_010548.2) and EGFP (IL-10-EGFP-LV) were generated by Cyagen (China). As a control, an empty EGFP expressing vector (EGFP-LV) was employed. MSCs at passage 1 were seeded into a 6-well plate for 24 h before being infected with the virus. When the cells were 30-40% confluent, the appropriate LV was injected to each well at a multiplicity of infection (MOI) of 10∶1 and incubated with the cells overnight. After being infected for 24 h, the medium was changed with fresh complete culture medium, and the MSCs were cultured for extra 48 h. Puromycin (2 μg/mL) was added to the infected MSCs and incubated for additional 48 h to remove uninfected MSCs. MSCs with both the IL-10 and EGFP genes (IL-10-LV-MSCs) as well as MSCs with only the EGFP gene (LV-MSCs) were then obtained. Infected MSCs (P5) were employed in subsequent experiments. Fluorescence microscopy and flow cytometry analyses were used to measure EGFP gene expression. Quantitative real-time PCR (qRT-PCR) and enzyme-linked immunosorbent assays (ELISA) were used to quantify IL-10 gene expression. The Cell Counting Kit-8 (CCK-8) (Absin, China) assay was used to create a growth curve. A microplate spectrometer was used to detect the absorbance at the wave length of 450 nm (SpectraMax190, Molecular Devices, USA). Cell surface markers were detected by flow cytometry.

    1.4 MSCs-Lymphocyte co-culture reactions in vitro

    Cell co-culture studies were used to examine the immunomodulatory effect of MSCs. As effector cells, lymphocytes were extracted from the spleens of mice with DSS-induced colitis, as follows. Spleens were dissected immediately after euthanasia and homogenized by grinding and passed through a 20G needle 3-4 times to obtain single-cell suspension. Cells were washed once with phosphate-buffered saline without calcium or magnesium (PBS) and red blood cells were lysed using RBC lysis buffer (Sigma-Aldrich, R7757). After neutralization with the complete medium [RPMI-1640 medium (Gibco, 22400089) supplemented with 10% heat-inactivated FBS and antibiotics mixture (100 U/mL penicillin and 100 mg/mL streptomycin (Beyotime Biotechnology, China)], cells were transferred to a culture dish and incubated at 37 ℃ with 5% CO2for 24 h to remove the adherent cells. The suspension cells were harvested as raw lymphocytes.

    For MSCs-Lymphocyte co-culture, 1×106lymphocytes activated by 5 μg/mL of PHA (Gibco, USA) were added into 6-well plats pre-seeded 1×105per well MSCs one night before. After co-culture for 72 h, the cells were harvested for flow cytometry analysis.

    1.5 MSCs-Macrophages co-culture reaction in vitro

    The immunomodulatory function of MSCs was tested using the RAW 264.7 gamma NO (-) (ATCC, CRL-2278) as a macrophage model. Transwell co-culture system (LABSELECT, China) was assembled by using 1×105macrophages and 1×105MSCs (at the ratio of 1∶1). Macrophages were seeded in 6-well plates. Transwell inserts were placed in additional 6-well plate, and then the MSCs were seeded in the transwell inserts. To develop the MSCs-Macrophages co-culture systems, Transwell inserts containing MSCs were transferred into the equivalent 6-well plates containing macrophages after cells had adhered for ca. 12 h. To stimulate TNF-α release, LPS (10 ng/mL) was introduced to the co-culture system. The culture supernatants were obtained after the cells had been co-cultured for 48 h, then the culture supernatants were harvested to analysis the TNF-α concentration by ELISA.

    1.6 qRT-PCR

    Excised colons and collected cells that were culturedinvitrowere homogenized to extract total RNA using the TRIzol (Solarbio Life Science, China). To acquire cDNA samples, reverse transcription was conducted using PrimeScript reverse transcriptase (TaKaRa, Japan). The qRT-PCR was carried out on an ABI Prism 7300 using the TB Green Premix Ex Taq kit (TaKaRa, Japan). The 2ΔCt method was used to compare relative amounts of target mRNA to GAPDH. All primers sequences were as follows:

    Table 1 The sequences of PCR and quantitative real-time PCR primers

    1.7 ELISAs

    Concentrations of IL-10 in the culture supernatants from transduced MSCs and concentrations of TNF-α in the culture supernatants from the MSCs-macrophages co-culture system were measured using ELISA kits (RK00016, RK00027 respectively, Abclonal, China) according to the manufacturer’s instructions.

    1.8 Flow cytometry

    MSCs that had received various treatments were collected, then flow cytometry analysis was performed. A FITC cannel was used to detect EGFP expression. To detect the surface marker expression, the MSCs were stained with fluorescence-conjugated mAbs against rat CD11b, CD45, CD90 and CD29 respectively. A flow cytometer was then used to study the cells (BD FACSCelesta, BD Biosciences, USA).

    ForinvitroT cell differentiation analysis, the cell surface was stained with anti-mouse CD4 and CD25 antibodies and the cells were fixed with the 1 × Fixation (#420801, BioLegend). The fixed cells were washed with 1×Staining Permeabilization Wash Buffer (10×) (#421002, BioLegend), followed by intracellular staining with anti-mouse IFN-γ and IL-17A antibodies. Then the cells were examined with a flow cytometer.

    1.9 Induction of experimental colitis models and administration of MSCs

    C57BL/6 mice were randomly split into five groups, including DSS+PBS, DSS+MSCs, DSS+LV-MSCs, DSS+IL-10-LV-MSCs and control groups (n=6 in each group). From day 0, the mice in DSS+PBS, DSS+MSCs, DSS+LV-MSCs and DSS+IL-10-LV-MSCs groups were given with 4 w/v% DSS in drinking water, while the control group received regular water. In DSS+MSCs, DSS+LV-MSCs and DSS+IL-10-LV-MSCs groups, the distinct populations of treated MSCs (1.0×106cells per mouse[22], pre-experiments shown that this dose can exert a stable therapeutic effect while avoiding cell aggregation and vascular embolism) were delivered by tail vein injection on day 3, 5 and 7 for a therapeutic research. Over the course of 11 days, the body weight, disease activity index (DAI) and survival rate were examined every day. The DAI was used to assess body weight loss, stool consistency, and rectal bleeding based on a previously published grading methodology[23]. On day 7, the colon was excised for macroscopic and histological investigation. Hematoxylin and eosin (H&E) staining and cytokine (IL-6, IL-1β and TNF-α) analyse using qRT-PCR were performed on colon tissues near rectum (about 3-5 cm).

    1.10 Histopathology

    The colons were embedded in paraffin after being treated with 4% paraformaldehyde. H&E was used to stain four-micrometer-thick slices. Under a light microscope (Olympus AX70, Japan), the degree of epithelial erosion, ulceration, vascular density and leukocyte infiltration were measured in the colon.

    1.11 Statistical analysis

    Data were presented as the mean ± standard error (S.D.). GraphPad Prism (v.7.00, La Jolla, CA, USA) was used to perform statistical analysis. One-way ANOVA with a post hoc Bonferroni correction was used to analyze differences across several groups.T-test was used to assess differences between two groups. A value ofP<0.05 was considered significant.

    2 Results

    2.1 Determination of IL-10 expression level in engineered MSCs

    MSCs infected with IL-10-EGFP-LV (IL-10-LV-MSCs) or EGFP-LV (LV-MSCs) both exhibited EGFP expressions at 48 h after the infection (Fig.1A). By puromycin selection, IL-10-LV-MSCs and LV-MSCs reached the purity to 78% and 87%, respectively (Fig.1B). To verify the correct expression of IL-10, qPCR analysis and ELISA were conducted. Compared with the MSCs group, the expression of IL-10 gene mRNA in IL-10-LV-MSCs was significantly increased, and the difference was statistically significant (P<0.001). qPCR analysis demonstrated that IL-10-EGFP-LV infection effetely inducedIL-10 gene expression in MSCs (Fig.1C). ELISA analysis indicated IL-10 expression exist in both wild type MSCs and LV-MSCs, but the content of IL-10 in the culture supernatant of MSCs cells after IL-10-EGFP-LV infection exceeded 300 pg/mL (Fig.1D).

    2.2 Phenotypic stability of MSCs after LV infection

    Results using microscopy indicated that LV infection showed no effect on the morphology of MSCs (Fig.1A). In addition, the results of flow cytometry analysis indicated that the expression levels of CD11b (0.9%, 1.0%) and CD45 (0.5%, 0.4%) (leukocyte markers) were not elevated in the LV-MSCs group and the IL-10-LV-MSCs group. Therefore, both IL-10-EGFP-LV and EGFP-LV infection did not induce MSCs differentiate into leukocytes (Fig.2A and 2B). Furthermore, MSCs markers, CD29 (96.9%, 91.4%) and CD90 (88.3%, 90.1%), were not significantly declined among MSCs that received different treatments (Fig.2C and 2D). The results of the CCK-8 assay showed no significant change in the number of MSCs after LV infection (P>0.05) (Fig.2C).

    2.3 Immunomodulatory potential of IL-10 overexpressing MSCs in vitro

    Engineered MScs were co-cultured with mice spleen lymphocytes or macrophages to determine their immunomodulatory potential. Lymphocytes were cultivated with or without MSCs for 3 days to investigate the effects of different populations of treated MSCs on Th cell differentiation. According to flow cytometry analyses (Fig.3A), IFN-γ+Th1 cells researched 34.2% of total Th cells without MSCs co-culture. The addition of the LV-MScs reduced the percentages of IFN-γ+Th1 cells to 26.5%. The lL-10-LV-MSCs reduced this percentages to 13.7%, indicating more effective inhibition on Th1 cells. In addition, the LV-MSCs lead an elevation on the percentages of IL-17A+Th17 cells (from 1.59% to 13.15%) IL-10-LV-MSCs, on the other hand, had no impact onTh17 cells (Fig.3B). Moreover, both kinds of MSCs could slightly but not significantly induce Treg cells differentiation (Fig.3C).

    A large proportion of pro-inflammatory TNF-α was secreted by macrophages. To examine the influences of the differently modified MSCs on the secretion of TNF-α from macrophages, macrophages were seeded in a 6 well plates and co-cultured with MSCs by a Transwell insert (Fig.3D). LPS stimulation induced a very high TNF-α level, but the addition of the IL-10-LV-MSCs significantly reversed the TNF-α level rising (P<0.001) (Fig.3E). Unexpectedly, the MSCs without IL-10 overexpression even improved TNF-α secretion (P<0.05).

    2.4 IL-10 overexpressing MSCs protected against DSS-induced colitis

    Mice were given a 4% DSS solution experienced rapid-onset colitis, which included weight loss, diarrhea, and bloody stool, and could not survive more than 8 days (Fig.4B, 4C and 4D). The DSS+IL-10-LV-MSCs group lost less weight and had lower DAI ratings than the DSS+PBS group (Fig.4C and 4D). A 7-day macroscopic examination of colons revealed a shorter colon length (no more than 5 cm) as well as significant hyperemia and inflammation in the DSS+PBS group (Fig.4E and 4F). Compared with the mice in the DSS+PBS group, colon length in mice treated with IL-10-LV-MSCs was longer without hyperemia, and the colon length has a statistically significant difference (P<0.01) (Fig.4E and 4F). Histological examination sections indicated that, though wild type of MSCs treatment assisted colon tissue repair to a certain extent, IL-10-LV-MSCs injection more significantly reduced submucosal edema, epithelium loss and inflammatory cell infiltration (Fig.4G).

    The impact of IL-10-LV-MSCs on colonic cytokines was also studied. The IL-10-LV-MSCs treatment group had lower mRNA levels of pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) in the inflamed colon than the wild type MSCs and blank LV vector treated MSCs group (P<0.001) (Fig.4H), indicating that the IL-10 overexpressing MSCs also reduced innate responsesinvivo.

    3 Discussion

    Despite recent advances in clinical therapies aimed at reducing inflammation, around 30% of IBD patients may not respond to biological therapy, and others may experience severe side effects[24]. A large number of preclinical studies have reported that MSCs can decrease intestinal inflammation without causing side effects[25], but these promising outcomes in animal models of IBD have yet to be duplicated in phase I/II clinical trials[12]. Therefore, several approaches have been developed to enhance the therapeutic properties of MSCs, including culture media optimization, combination with other molecules or other cell therapy, scaffolding method and genetic modification[22]. In this study, for the first time, the effects ofIL-10 gene edited BM-MSCs in an IBD mouse model were reported.

    Fig.1 MSCs expression of EGFP and IL-10 after LV infection (A) The fluorescence micrograph (left) and light micrograph (middle) of MSCs and MSCs infected with different types of LVs after 48 hours, green indicates EGFP. Scale bars, 100 μm. (B) Representative flow cytometry pictures of EGFP expression in wild type MSCs and MSCs infected with the indicated LV, as well as the percentage of EGFP positive cells in MSCs (n=3,****P<0.0001). (C) The amount of IL-10 mRNA in wild type MSCs and MSCs infected with the indicated LV (n=3, NS: no significant difference,***P<0.001). (D) The protein level of IL-10 in the culture supernatant of MSCs infected with various kinds of LV (n=3, NS: no significant difference,****P<0.0001). MSCs represents wild type MSCs, IL-10-LV-MSCs and LV-MSCs represents MSCs infected with IL-10-EGFP-LV or EGFP-LV

    Fig.2 Phenotypic characterization of MSCs after LV infection (A) Flow cytometry analysis of CD11b in MSCs had undergone the indicated treatments. (B) Flow cytometry analysis of CD45 in MSCs had undergone the indicated treatments. (C) Flow cytometry analysis of CD29 in MSCs had undergone the indicated treatments. (D) Flow cytometry analysis of CD90 in MSCs had undergone the indicated treatments. (E) Cell proliferation rates of MSCs given the indicated treatments, CCK-8 assay was used to determine (n=3, NS: no significant difference)

    Fig.3 Immunomodulatory potential assays of engineered MSCs (A) Quantitative analysis of Th1 cells in spleen lymphocytes of DSS mice co-cultured with engineered MSCs (n=3, NS: no significant difference,*P<0.05,**P<0.01). (B) Quantitative analysis of Th17 cells in spleen lymphocytes of DSS mice co-cultured with engineered MSCs (n=3, NS: no significant difference,*P<0.05). (C) Quantitative analysis of Treg cells in spleen lymphocytes of DSS mice co-cultured with engineered MSCs (n=3, NS: no significant difference). (D) Transwell co-culture model of macrophages with Engineered MSCs. (E) ELISA analysis of TNF-α in supernatants of co-cultured macrophages and MSCs (n=3,*P<0.05,***P<0.001,****P<0.0001)

    Fig.4 Evaluation for the protective effects of engineered MSCs on DSS-induced colitis mice (A) Schematic diagram of the treatment of IBD with engineered mesenchymal stem cells overexpressing IL-10. (B) Survival analysis of mice in each group was performed (n=6). (C) Body weight of mice in each group was recorded daily (n=6,**P<0.01). (D) DAI of mice in each group was recorded daily (n=6,***P<0.001,****P<0.0001). (E) Colons excised from mice received three times different treatments were photographed. (F) Colon length statistical analysis (n=6, NS: no significant difference,*P<0.05;**P<0.01). (G) H&E staining was used to evaluate colon sections from mice that had received various treatments. Scale bars, 100 μm. (H) Expression of inflammatory factors in mice from each group, IL-6 (left), TNF-α (middle), IL-1β (right) (*P<0.05,**P<0.01,***P<0.001)

    In this study, the LV vectors were used to deliver potent therapeutic genes to MSCs. In clinical research, however, problems have been found for the safety of MSCs genetically engineered with stable DNA[26, 27]. In the current work, phenotypic characterization analysis was used to assess the safety of modified MSCs. The results of this work elucidated that LV infection had no impact on MSCs phenotype or cell proliferation rate.

    In the present study, the BM-MSCs were armed with overexpressingIL-10 gene to construct a bioreactor which can continuously produce high level IL-10. IL-10R includes two distinct chains: IL-10R1 expressed mostly on monocytes and macrophages, and IL-10R2 could be found in most cell types[28]. The immunosuppressive IL-10 was originally reported to affect many important functions of macrophages from phagocytosis to the production of cytokines[28]. IL-10 also blocks the proliferation of Th17 cells via the directly binding on IL-10 receptor which is highly expressed on Th17 cells. Meanwhile, the immunomodulatory capacity of MSCs could be altered by environmental signals[29], possibly including IL-10. Because IL-10 was found to be necessary for MSCs maintenance in bone marrow[30]and to facilitate MSCs osteogenesis under an osteogenic condition[31]. An in-depth transcriptome and proteomic analysis is needed to clarify whether overexpressing IL-10 can improve the immunomodulatory effects of MSCs themselves.

    The immunomodulatory effects ofIL-10 gene-modified BM-MSCs was explored via immune cells and MSCs co-culture systemsinvitro, and the treatment potential on IBD of the genetically-engineered BM-MSCs was on DSS induced colitis mouse model. When compared to wild type MSCs, MSCs overexpressing IL-10 showed an elevated ability to attenuate Th1 and Th17 responses, as well as a strengthened potential in inhibiting TNF-α secretion from activated macrophages. Furthermore, we demonstrated that systemic administration of IL-10-LV-MSCs substantially ameliorated the colon length, DAI and colonic cytokine expression in the DSS induced colitis mouse model.

    A complex relationship between Th17 cells and IBD has been reported in recent literatures. Increased activation of Th17 cells and expression of Th17-related cytokines (such as IL-17 and IL-22) were present in IBD patients[3]. From an evolutionary perspective, Th17 cells play an important role in host defense against bacterial and fungal infection[32]. However,under disease condition especially sustained exposure to IL-1 and IL-23,Th17 cells can cause severe local tissue damage by recruit macrophages and granulocytes[33]. One aspect of the variability of the immunomodulatory function of MSCs is related to their regulatory effects on Th17 cells: MSCs inhibit Th17 cells differentiation and function[34], or induce Th17 differentiation[35]under different research background. In our study, the Th17 induction effect of MSCs was abolished by IL-10-overexpressing modification. This change may contribute to the improvement of therapeutic effect on IBD.

    In summary, BM-MSCs modified by LV-mediated IL-10 overexpression showed enhanced immunomodulatory potentials without affection on the phenotypic characterization. Systemically administration of the engineered MSCs remarkably protected mice suffering from experimental colitis. This technique of using engineered MSCs to relieve mucosal inflammatory responses is a potential therapeutic approach that might be useful in the treatment of IBD.

    Acknowledgments

    We thank Dr.Sheng He for his kinlly sharing of the cell strain KAW 264.

    99久久精品热视频| 涩涩av久久男人的天堂| 一个人免费看片子| 国产av精品麻豆| 国产一区二区在线观看日韩| 久久ye,这里只有精品| 日韩欧美精品免费久久| 观看免费一级毛片| 在线天堂最新版资源| 午夜av观看不卡| 午夜久久久在线观看| 卡戴珊不雅视频在线播放| 99热6这里只有精品| 久久国产精品男人的天堂亚洲 | 久久久精品免费免费高清| 全区人妻精品视频| 久久精品久久久久久久性| 久久久精品免费免费高清| 亚洲精品aⅴ在线观看| 九九久久精品国产亚洲av麻豆| 久久 成人 亚洲| a级毛色黄片| 秋霞伦理黄片| 天天操日日干夜夜撸| 各种免费的搞黄视频| 久久久久久久精品精品| 久久久久久久国产电影| 成年人免费黄色播放视频 | 最新的欧美精品一区二区| freevideosex欧美| 桃花免费在线播放| 免费观看a级毛片全部| 成人毛片a级毛片在线播放| 久久久久久久久久久免费av| 亚洲第一区二区三区不卡| 蜜臀久久99精品久久宅男| 国产极品粉嫩免费观看在线 | 91午夜精品亚洲一区二区三区| av播播在线观看一区| 精品国产一区二区久久| 国产成人精品婷婷| 天堂8中文在线网| 一区二区三区乱码不卡18| 国产精品国产三级国产专区5o| 观看免费一级毛片| a级片在线免费高清观看视频| 久久久久久久久久久久大奶| 久久ye,这里只有精品| 秋霞在线观看毛片| 一个人看视频在线观看www免费| 亚洲精品乱码久久久久久按摩| 有码 亚洲区| 免费观看的影片在线观看| videos熟女内射| 国产男女超爽视频在线观看| www.色视频.com| 国模一区二区三区四区视频| 亚洲图色成人| 欧美日韩一区二区视频在线观看视频在线| 日韩精品有码人妻一区| 日日摸夜夜添夜夜爱| 免费黄网站久久成人精品| 三级经典国产精品| 女人精品久久久久毛片| 亚洲国产最新在线播放| 大又大粗又爽又黄少妇毛片口| 大话2 男鬼变身卡| av一本久久久久| 久久精品夜色国产| 国产探花极品一区二区| 日本av免费视频播放| 国产精品女同一区二区软件| 久久精品国产亚洲av天美| 免费av不卡在线播放| 日日撸夜夜添| 曰老女人黄片| 国产毛片在线视频| 最黄视频免费看| 啦啦啦视频在线资源免费观看| 国产欧美日韩一区二区三区在线 | 视频区图区小说| 久久国产亚洲av麻豆专区| 欧美日韩亚洲高清精品| 亚洲欧美日韩东京热| 日本色播在线视频| 一区二区三区乱码不卡18| 亚洲av成人精品一区久久| 熟女电影av网| 久久久久人妻精品一区果冻| 精品99又大又爽又粗少妇毛片| 性高湖久久久久久久久免费观看| 国产精品人妻久久久影院| 亚洲四区av| 男人添女人高潮全过程视频| 在线观看免费日韩欧美大片 | 啦啦啦啦在线视频资源| 久久久久久久久久人人人人人人| xxx大片免费视频| 麻豆成人午夜福利视频| 人妻一区二区av| av福利片在线| 在现免费观看毛片| 亚洲精品一二三| 街头女战士在线观看网站| 日日爽夜夜爽网站| 久久久久久久亚洲中文字幕| 久久免费观看电影| 久久综合国产亚洲精品| av在线app专区| 亚洲电影在线观看av| 国产男人的电影天堂91| 青春草国产在线视频| 在线精品无人区一区二区三| 日日撸夜夜添| 一级黄片播放器| 精品人妻熟女毛片av久久网站| 欧美日韩精品成人综合77777| 久久韩国三级中文字幕| 国产免费又黄又爽又色| 永久网站在线| 久久综合国产亚洲精品| 观看免费一级毛片| 久久99精品国语久久久| 精品少妇久久久久久888优播| 久久久久久久国产电影| 国内少妇人妻偷人精品xxx网站| 成人特级av手机在线观看| 婷婷色av中文字幕| 国产熟女欧美一区二区| 国产亚洲午夜精品一区二区久久| 亚洲精品中文字幕在线视频 | 综合色丁香网| 新久久久久国产一级毛片| 两个人的视频大全免费| 久久久久久久精品精品| 在线观看人妻少妇| 天天躁夜夜躁狠狠久久av| 成人影院久久| 国产深夜福利视频在线观看| 国内少妇人妻偷人精品xxx网站| 国产综合精华液| 久久久久久久国产电影| 久久热精品热| 嫩草影院入口| 成年女人在线观看亚洲视频| 精华霜和精华液先用哪个| 在线亚洲精品国产二区图片欧美 | 日日啪夜夜撸| 2018国产大陆天天弄谢| 免费在线观看成人毛片| 日韩一区二区视频免费看| 国产女主播在线喷水免费视频网站| 成人漫画全彩无遮挡| 午夜精品国产一区二区电影| 男女啪啪激烈高潮av片| 嫩草影院入口| 日韩成人伦理影院| 亚洲av男天堂| 丝袜脚勾引网站| 内射极品少妇av片p| 久久久久精品久久久久真实原创| 丝袜脚勾引网站| 十八禁网站网址无遮挡 | 久热这里只有精品99| 亚洲天堂av无毛| 精品国产国语对白av| 丝袜喷水一区| 免费高清在线观看视频在线观看| 日日爽夜夜爽网站| 少妇的逼水好多| 日本色播在线视频| 下体分泌物呈黄色| 欧美激情极品国产一区二区三区 | 久久精品国产自在天天线| 欧美日韩国产mv在线观看视频| 成年女人在线观看亚洲视频| 一区二区av电影网| 一级黄片播放器| h日本视频在线播放| 国产男人的电影天堂91| 丝瓜视频免费看黄片| 永久免费av网站大全| 精品少妇久久久久久888优播| 91成人精品电影| 天天躁夜夜躁狠狠久久av| 亚洲欧美日韩卡通动漫| 日韩精品免费视频一区二区三区 | 国产一区二区三区综合在线观看 | 亚洲美女视频黄频| 男人爽女人下面视频在线观看| 国产成人午夜福利电影在线观看| 成人国产av品久久久| 亚洲国产精品国产精品| 亚洲精品,欧美精品| 亚洲婷婷狠狠爱综合网| 99久久精品一区二区三区| 精华霜和精华液先用哪个| 男人和女人高潮做爰伦理| 中文资源天堂在线| 久久人人爽人人爽人人片va| 亚洲美女搞黄在线观看| 蜜臀久久99精品久久宅男| 热re99久久国产66热| 80岁老熟妇乱子伦牲交| 街头女战士在线观看网站| 夜夜骑夜夜射夜夜干| 亚洲精品一二三| 久久久久久伊人网av| 少妇 在线观看| 久久久国产精品麻豆| 高清av免费在线| 久热久热在线精品观看| 久久久亚洲精品成人影院| 日日摸夜夜添夜夜爱| 日韩精品免费视频一区二区三区 | 欧美最新免费一区二区三区| 欧美性感艳星| 99热这里只有是精品50| 国产午夜精品久久久久久一区二区三区| 大片免费播放器 马上看| 国产午夜精品一二区理论片| 精品午夜福利在线看| 免费看av在线观看网站| 免费观看av网站的网址| 午夜免费鲁丝| av视频免费观看在线观看| 视频区图区小说| 在线免费观看不下载黄p国产| 三级经典国产精品| 亚洲情色 制服丝袜| videos熟女内射| 亚洲美女黄色视频免费看| 国产在视频线精品| 五月开心婷婷网| 97在线视频观看| 久久久久久久久久久丰满| 亚洲精品自拍成人| 老司机亚洲免费影院| 国产成人freesex在线| 欧美精品国产亚洲| 老女人水多毛片| 中文欧美无线码| 日韩亚洲欧美综合| 亚洲成人av在线免费| 国产精品一区二区在线不卡| 美女中出高潮动态图| 国产午夜精品久久久久久一区二区三区| 色婷婷久久久亚洲欧美| 国产av码专区亚洲av| 偷拍熟女少妇极品色| 久久久a久久爽久久v久久| 日本午夜av视频| 亚洲欧美一区二区三区国产| 成年美女黄网站色视频大全免费 | 国产91av在线免费观看| 日本与韩国留学比较| 欧美 亚洲 国产 日韩一| 亚洲中文av在线| av一本久久久久| 亚洲国产毛片av蜜桃av| 精品久久久久久电影网| 国产精品一二三区在线看| 在线看a的网站| 国产免费视频播放在线视频| 国产在线视频一区二区| 国产日韩一区二区三区精品不卡 | 日韩成人伦理影院| 成人特级av手机在线观看| 国产色爽女视频免费观看| 欧美bdsm另类| 国产无遮挡羞羞视频在线观看| 欧美三级亚洲精品| 国产在视频线精品| 性高湖久久久久久久久免费观看| 成人漫画全彩无遮挡| 男女无遮挡免费网站观看| 亚洲美女视频黄频| 久久久久久人妻| 蜜臀久久99精品久久宅男| 国产老妇伦熟女老妇高清| 久久久久久久久久久免费av| 久久人人爽av亚洲精品天堂| 国产又色又爽无遮挡免| 久久久国产一区二区| 丁香六月天网| 极品人妻少妇av视频| 香蕉精品网在线| 男女边摸边吃奶| 久久午夜福利片| 99re6热这里在线精品视频| 精品久久久久久久久av| av在线老鸭窝| 日日啪夜夜撸| 亚洲精品第二区| 人体艺术视频欧美日本| 六月丁香七月| 少妇高潮的动态图| 欧美性感艳星| 麻豆成人av视频| 精品久久国产蜜桃| 中文字幕久久专区| 啦啦啦在线观看免费高清www| 超碰97精品在线观看| 国内少妇人妻偷人精品xxx网站| 夜夜骑夜夜射夜夜干| 久久久国产精品麻豆| 久久99热这里只频精品6学生| 97超碰精品成人国产| 亚洲av福利一区| 亚洲国产精品国产精品| 国产成人91sexporn| 香蕉精品网在线| 国产精品成人在线| 免费在线观看成人毛片| 亚洲真实伦在线观看| 人妻少妇偷人精品九色| 边亲边吃奶的免费视频| 中文字幕精品免费在线观看视频 | 国产在线视频一区二区| 久久精品久久精品一区二区三区| 国产在线视频一区二区| 国精品久久久久久国模美| 久久亚洲国产成人精品v| 国国产精品蜜臀av免费| 99久久精品一区二区三区| 又粗又硬又长又爽又黄的视频| 精品人妻一区二区三区麻豆| 女人精品久久久久毛片| 国产高清三级在线| 大码成人一级视频| 亚洲第一av免费看| 国产一区二区三区av在线| 国产视频内射| 免费人妻精品一区二区三区视频| 少妇熟女欧美另类| 亚洲精品久久久久久婷婷小说| 国产淫片久久久久久久久| 国产熟女欧美一区二区| av不卡在线播放| 欧美日韩一区二区视频在线观看视频在线| 久久国内精品自在自线图片| 亚洲电影在线观看av| 91久久精品国产一区二区成人| 欧美精品高潮呻吟av久久| 纵有疾风起免费观看全集完整版| 九九久久精品国产亚洲av麻豆| 久久ye,这里只有精品| 另类精品久久| a级片在线免费高清观看视频| 26uuu在线亚洲综合色| 精品久久久精品久久久| 一级毛片aaaaaa免费看小| 深夜a级毛片| 国内精品宾馆在线| 色5月婷婷丁香| 少妇人妻久久综合中文| 亚洲欧美一区二区三区国产| 国产白丝娇喘喷水9色精品| 九色成人免费人妻av| 内地一区二区视频在线| 日韩av在线免费看完整版不卡| 国产免费一区二区三区四区乱码| 中文资源天堂在线| 我的女老师完整版在线观看| 青春草国产在线视频| 日本免费在线观看一区| 天堂8中文在线网| 久久久a久久爽久久v久久| 哪个播放器可以免费观看大片| 亚洲四区av| 久久女婷五月综合色啪小说| 亚洲一级一片aⅴ在线观看| videos熟女内射| 色吧在线观看| 99热这里只有是精品50| 日本猛色少妇xxxxx猛交久久| 亚洲三级黄色毛片| xxx大片免费视频| 国产色婷婷99| 男女边吃奶边做爰视频| 国产又色又爽无遮挡免| 观看美女的网站| 不卡视频在线观看欧美| 精品少妇内射三级| 精品国产一区二区三区久久久樱花| 王馨瑶露胸无遮挡在线观看| 国产熟女欧美一区二区| av女优亚洲男人天堂| 日韩欧美 国产精品| 男人爽女人下面视频在线观看| 永久免费av网站大全| 国产成人aa在线观看| 亚洲av国产av综合av卡| 国产精品伦人一区二区| 又大又黄又爽视频免费| 精品亚洲成国产av| 亚洲自偷自拍三级| 午夜视频国产福利| 丰满迷人的少妇在线观看| 欧美人与善性xxx| 国产高清有码在线观看视频| 亚洲成人av在线免费| 春色校园在线视频观看| 欧美xxⅹ黑人| 欧美xxxx性猛交bbbb| 久久99精品国语久久久| 国产欧美日韩一区二区三区在线 | 好男人视频免费观看在线| 国产精品.久久久| 成人无遮挡网站| 欧美三级亚洲精品| 狂野欧美白嫩少妇大欣赏| 久久99精品国语久久久| 亚洲人成网站在线播| 草草在线视频免费看| 免费黄频网站在线观看国产| 久久人人爽人人爽人人片va| h视频一区二区三区| 精品一区二区免费观看| 中文字幕免费在线视频6| 精品国产一区二区久久| 日本欧美视频一区| 国产精品欧美亚洲77777| 97超碰精品成人国产| 日本猛色少妇xxxxx猛交久久| 久久精品国产鲁丝片午夜精品| 最新中文字幕久久久久| 中文字幕人妻熟人妻熟丝袜美| 国产亚洲5aaaaa淫片| 亚洲国产色片| 亚洲精品日韩在线中文字幕| 欧美日韩亚洲高清精品| 我的女老师完整版在线观看| 99久久精品一区二区三区| 青春草亚洲视频在线观看| 中国美白少妇内射xxxbb| 91在线精品国自产拍蜜月| 女性生殖器流出的白浆| 99九九在线精品视频 | 久久精品夜色国产| 国产 一区精品| 久久精品国产亚洲av天美| 爱豆传媒免费全集在线观看| 久久毛片免费看一区二区三区| 综合色丁香网| 大陆偷拍与自拍| 亚洲四区av| 日韩av在线免费看完整版不卡| 妹子高潮喷水视频| 日韩制服骚丝袜av| 日本欧美视频一区| 亚洲av电影在线观看一区二区三区| 高清视频免费观看一区二区| 在线观看免费高清a一片| 九九在线视频观看精品| 精品人妻熟女av久视频| 69精品国产乱码久久久| 国产色爽女视频免费观看| 国产亚洲午夜精品一区二区久久| 国产探花极品一区二区| 国产在视频线精品| 婷婷色麻豆天堂久久| 国产精品久久久久久久久免| 美女国产视频在线观看| 两个人免费观看高清视频 | 三级经典国产精品| 在线 av 中文字幕| 国产极品天堂在线| 午夜精品国产一区二区电影| av又黄又爽大尺度在线免费看| 人人妻人人看人人澡| 久久6这里有精品| 欧美日韩一区二区视频在线观看视频在线| 99九九线精品视频在线观看视频| 国产淫片久久久久久久久| 在线观看免费日韩欧美大片 | 国产男女超爽视频在线观看| 一本一本综合久久| 中文欧美无线码| 久久久久久久久久久丰满| 午夜激情久久久久久久| 久久av网站| 精品卡一卡二卡四卡免费| 边亲边吃奶的免费视频| 国产一级毛片在线| 我的女老师完整版在线观看| 蜜桃在线观看..| 天美传媒精品一区二区| 熟女电影av网| 人妻系列 视频| 草草在线视频免费看| 新久久久久国产一级毛片| 多毛熟女@视频| 欧美日本中文国产一区发布| 日本欧美国产在线视频| 亚洲美女黄色视频免费看| 又爽又黄a免费视频| 欧美精品国产亚洲| 国产在线视频一区二区| 亚洲四区av| 国产精品成人在线| 老女人水多毛片| 搡老乐熟女国产| 少妇高潮的动态图| 欧美日韩av久久| 精品久久久久久久久亚洲| 亚洲av成人精品一区久久| 丰满迷人的少妇在线观看| 久久国产精品大桥未久av | 国产欧美日韩综合在线一区二区 | 精品国产一区二区久久| 两个人免费观看高清视频 | 两个人的视频大全免费| 亚洲成人一二三区av| 最近最新中文字幕免费大全7| 亚洲丝袜综合中文字幕| 精品久久国产蜜桃| 免费看不卡的av| 久久久久久久精品精品| 国产免费福利视频在线观看| 性色av一级| 免费播放大片免费观看视频在线观看| 成年女人在线观看亚洲视频| 黄色毛片三级朝国网站 | 国产欧美日韩一区二区三区在线 | 久久99精品国语久久久| 日韩制服骚丝袜av| 97在线人人人人妻| 欧美变态另类bdsm刘玥| 亚洲内射少妇av| tube8黄色片| 日韩大片免费观看网站| av黄色大香蕉| 免费播放大片免费观看视频在线观看| 一级毛片电影观看| 18禁动态无遮挡网站| 国产永久视频网站| 一本大道久久a久久精品| 久久久国产精品麻豆| 青青草视频在线视频观看| av视频免费观看在线观看| 国产亚洲最大av| 亚洲国产欧美日韩在线播放 | 九色成人免费人妻av| 亚洲国产精品999| 国产精品久久久久久av不卡| 一级毛片黄色毛片免费观看视频| 亚洲婷婷狠狠爱综合网| 精品熟女少妇av免费看| 国产在视频线精品| 在线看a的网站| 最近2019中文字幕mv第一页| 久久热精品热| 国产日韩欧美视频二区| 一区二区三区精品91| 丝袜在线中文字幕| 日韩精品有码人妻一区| 涩涩av久久男人的天堂| av又黄又爽大尺度在线免费看| h视频一区二区三区| 久久ye,这里只有精品| 国产探花极品一区二区| 日日摸夜夜添夜夜爱| 精品国产一区二区三区久久久樱花| 免费av中文字幕在线| 亚洲高清免费不卡视频| 国产在线免费精品| 精品久久久久久电影网| 一级爰片在线观看| 一级二级三级毛片免费看| 老司机影院毛片| 美女cb高潮喷水在线观看| 天天操日日干夜夜撸| 久久久久国产精品人妻一区二区| 一区在线观看完整版| 中文字幕人妻熟人妻熟丝袜美| xxx大片免费视频| 99久久精品一区二区三区| 中国国产av一级| 日日摸夜夜添夜夜添av毛片| 九草在线视频观看| 一二三四中文在线观看免费高清| 免费大片黄手机在线观看| 久久久久视频综合| 黄色欧美视频在线观看| 成人影院久久| 伦理电影大哥的女人| 国语对白做爰xxxⅹ性视频网站| 天堂中文最新版在线下载| 精品人妻熟女av久视频| 老司机影院毛片| 男男h啪啪无遮挡| 最近中文字幕2019免费版| 人妻人人澡人人爽人人| 亚洲精品亚洲一区二区| 久久精品国产亚洲av天美| 亚洲一级一片aⅴ在线观看| 久久婷婷青草| 综合色丁香网| 欧美最新免费一区二区三区| 久久人妻熟女aⅴ| 久久国产亚洲av麻豆专区| 国产精品.久久久| 美女cb高潮喷水在线观看| a级毛片在线看网站| 色婷婷av一区二区三区视频| 国产精品久久久久久久久免| 精品国产乱码久久久久久小说| 国产深夜福利视频在线观看| 日韩精品有码人妻一区| 久久久久久久亚洲中文字幕| 国国产精品蜜臀av免费| 国产伦在线观看视频一区| 国产免费视频播放在线视频| 国产成人午夜福利电影在线观看|